Brief: S2Medical: Epiprotect Will Increase Reimbursement Rates And Create Market Advantages

S2Medical AB (publ)

16/09/2022 10:56

Sept 16 (Reuters) - S2Medical AB (publ)  S2ME.ST :
    * EPIPROTECT CLASSIFIED AS SKIN SUBSTITUTE WILL INCREASE
REIMBURSEMENT RATES AND CREATE MARKET ADVANTAGES
    * CHANGE IN PRODUCT CATEGORY WILL OPEN UP TO A HIGHER LEVEL
OF
REIMBURSEMENT WITHIN HEALTHCARE FIELD

Source text for Eikon:  ID:nWkr8mhm4K 
Further company coverage:  S2ME.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))